Cortex Pharmaceuticals Q4 shr loss $ 0 . 14 . Cortex Pharmaceuticals , Inc . Condensed Statements of Operations ( in thousands , except per share data ) ( Unaudited ) Three months ended June 30 , Years ended June 30 , 1996 1995 1996 1995Research , license and grant revenues $ - - - $ - - - $ - - - $ - - - Operating expenses : Research and development 644 993 2 , 677 4 , 139 General and administrative 391 387 1 , 644 1 , 665Settlement with Alkermes , Inc . - - - 1 , 228 - - - 1 , 228Total operating expenses 1 , 035 2 , 608 4 , 321 7 , 032 Loss from operations ( 1 , 035 ) ( 2 , 608 ) ( 4 , 321 ) ( 7 , 032 ) Interest income , net 46 39 163 196 Net loss ( 989 ) ( 2 , 569 ) ( 4 , 158 ) ( 6 , 836 ) Shares used in computing net loss per share 7 , 357 6 , 078 6 , 533 6 , 075 Net loss per share ( 0 . 14 ) ( 0 . 43 ) ( 0 . 64 ) ( 1 . 13 ) 
